APOE, MAPT, SNCA, and Cognitive Performance in Parkinson Disease

IMPORTANCE: Cognitive impairment (CI) is a common and disabling problem in Parkinson’s disease (PD) that is not well understood and is difficult to treat. Identification of genetic variants that influence the rate of cognitive decline or pattern of early cognitive deficits in PD might provide a clea...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:JAMA Neurol
Κύριοι συγγραφείς: Mata, Ignacio F., Leverenz, James B., Weintraub, Daniel, Trojanowski, John Q., Hurtig, Howard I., Van Deerlin, Vivianna M., Ritz, Beate, Rausch, Rebecca, Rhodes, Shannon L, Factor, Stewart A., Wood-Siverio, Cathy, Quinn, Joseph F., Chung, Kathryn A., Peterson, Amie L., Espay, Alberto J., Revilla, Fredy J., Devoto, Johnna, Hu, Shu-Ching, Cholerton, Brenna A., Wan, Jia Y., Montine, Thomas J., Edwards, Karen L., Zabetian, Cyrus P.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2014
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4227942/
https://ncbi.nlm.nih.gov/pubmed/25178429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2014.1455
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια